Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Icosagen, a CRDMO with expertise in innovative antibody research and production, announced a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC), a translational drug discovery organization tapping on a broad network in ...
read more
Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle (RRPV) Consortium to conduct its Decentralized Home Focus COVID-19 ...
read more
Science 37 Holdings, Inc. announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite™ model and internal processes,...
read more
evitria AG, a global antibody expression service provider located in Zurich, Switzerland, has entered into a non-exclusive bYlok® bispecific pairing technology license agreement with Lonza. Lonza’s bYlok® technology redefines IgG-like bispecific ...
read more
PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announced the opeing of its radiopharmaceutical production and research facility in the Bronx, New York.
read more
Minaris Regenerative Medicine, a global manufacturing partner to the cell and gene therapy industry, today announced that the first commercial manufacturing run of LYFGENIA – a one-time gene therapy for the treatment of sickle cell disease developed ...
read more
ProQR Therapeutics, a company dedicated to changing lives through transformative RNA therapies, announced new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical proof of concept data for its...
read more
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos™ in internal and external product development and manufacturing programs, today announced promising preclinical research results that strongly support the ...
read more
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023. The Contract Development & Manufacturing Organization (CDMO) recently became a member of SBTi and is therefore committed to meeting strict CO2 ...
read more
Myonex has completed the previously announced acquisition of CREAPHARM's pharmaceutical services business. This transaction combines capabilities and flexibility to serve pharmaceutical and biotech companies in both clinical and commercial stages, ...
read more
Wacker Biotech US, a subsidiary of WACKER, specializing in the fermentative production of plasmid DNA (pDNA), is expanding its mRNA and protein production.
read more
Rentschler Biopharma SE announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary, effective May 1, 2024. In this newly created position, Dr. Cushing will ...
read more
Kindeva Drug Delivery announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility.
read more
Adare Pharma Solutions has announced expansions of its high potency handling capabilities in the United States and Europe. In the United States, a second high potency suite is being added to Adare’s 128,000 sq ft (12,000 sq m) Orthodox Street ...
read more
Genomics plc and GSK announced a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve understanding of disease risk and patient selection, which could support optimization of trial design. ...
read more